TREM2 variants in Alzheimer's disease.
暂无分享,去创建一个
A. Singleton | J. Hardy | P. S. St George-Hyslop | L. Hazrati | J. Powell | K. Morgan | J. Collinge | A. Goate | J. Kauwe | R. Guerreiro | M. Carrasquillo | S. Younkin | Julie Williams | J. Lambert | P. Amouyel | Carlos Cruchaga | E. Rogaeva | J. Bras | C. Sassi | E. Majounie | R. Rademakers | J. Pocock | Aleksandra M. Wojtas | T. Lashley | R. Rademakers | J. Hardy | J. Powell
[1] A. Singleton,et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. , 2012, JAMA neurology.
[2] L. Hazrati,et al. Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism , 2012, Neurobiology of Aging.
[3] J. Hardy,et al. Microglia, Alzheimer's Disease, and Complement , 2012, International journal of Alzheimer's disease.
[4] Joseph K. Pickrell,et al. A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes , 2012, Science.
[5] R. Guerreiro,et al. Complement receptor 1 (CR1) and Alzheimer's disease. , 2012, Immunobiology.
[6] A. Singleton,et al. Repeat expansion in C9ORF72 in Alzheimer's disease. , 2012, The New England journal of medicine.
[7] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[8] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[9] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[10] A. Singleton,et al. Towards a complete resolution of the genetic architecture of disease. , 2010, Trends in genetics : TIG.
[11] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[12] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[13] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[14] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[15] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[16] M. Hamshere,et al. Meta-analysis of linkage studies for Alzheimer's disease—A web resource , 2009, Neurobiology of Aging.
[17] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[18] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[19] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[20] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[21] Nancy F. Hansen,et al. Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.
[22] I. Bechmann,et al. TREM2 is upregulated in amyloid plaque‐associated microglia in aged APP23 transgenic mice , 2008, Glia.
[23] L. Piccio,et al. Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis , 2007, European journal of immunology.
[24] H. Neumann,et al. TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis , 2007, PLoS medicine.
[25] H. Neumann,et al. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis , 2007, Journal of Neuroimmunology.
[26] B. Melchior,et al. Microglia and the control of autoreactive T cell responses , 2006, Neurochemistry International.
[27] L. Peltonen,et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.
[28] S. Turner,et al. Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695* , 2001, The Journal of Biological Chemistry.
[29] Ralph A. Nixon,et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.
[30] P. S. St George-Hyslop,et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. , 2000, Nature.
[31] K. Welsh-Bohmer,et al. APOE-ε4 count predicts age when prevalence of AD increases, then declines , 1999, Neurology.
[32] B W Wyse,et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. , 1999, Neurology.
[33] J. Rommens,et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.
[34] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[35] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.